Contract negotiations between Mount Sinai and Anthem Blue Cross Blue Shield broke down this week, leaving the health system ...

Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid ...

Grow Therapy's Series D funding was led by TCV and Growth Equity at Goldman Sachs Alternatives, with participation from BCI, ...

CEO Kempton Presley provided an overview of its medication adherence technology and how it addresses challenges specific to dual-eligibles. Vice President, Product Management, Data and Ecosystem ...

Health data company Health Gorilla filed a motion to dismiss a lawsuit from Epic and several healthcare providers alleging ...

Parachute Health has raised a Series B round on the heels of another fundraise earlier this year for a total of $15 million. Insight Venture Partners became the latest investors to back the business ...

Medicare is making two major changes to how it pays for cardiac care. Beginning this year, the Centers for Medicare & Medicaid Services (CMS) are moving away from paying solely for services performed ...

After Congress failed to pass a funding bill, the government shut down early Wednesday morning, which has significant implications for healthcare, including the future of telehealth flexibilities and ...

In the past couple of years, payers have come under scrutiny as they increasingly adopt AI tools to automate tasks like the claims review and prior authorization requests. Providers have voiced ...

Gilead Sciences is expanding its cell therapy pipeline and technological capabilities through the $7.8 billion acquisition of Arcellx, its partner in the development of a multiple myeloma treatment ...

ICHRA — Individual Coverage Health Reimbursement Arrangement — seems to be the new buzzword of 2025. The interest in ICHRA stems from dissatisfaction with traditional group health insurance. The ...

Much of President Donald Trump’s Tuesday State of the Union address centered on immigration and tariffs. However, he also addressed several healthcare issues, including a renewed criticism of the ...